Mutations of MSH2 are four-fold more frequent in Lynch syndrome with BC than mutations of MLH1, the candidate gene most often affected in Lynch syndrome (up to 20% of patients harboring MSH2 mutations have BC) [63, 87]. This evidence concerns the gene MSH2 and breast cancer.